CoSMO PRP (Platelet-rich plasma)

Síntese do Projeto

Platelet-rich plasma (PRP) is an autologous biological product obtained from a quantity of venous blood. The centrifugation process is responsible for obtaining a platelet concentrate containing many proteins and growth factors. By definition, PRP contains many platelets above normal physiological levels.

Currently, there are many solutions to obtain PRP to be used in a wide variety of clinical procedures, either for aesthetic purposes or to treat pathologies. However, mainly due to the broad commercial interest in using PRP in professional sports, an increase in its use has been seen in the musculoskeletal field.

Plasma is the liquid portion of blood that provides the medium for blood cells to circulate through the body and is composed primarily of water and protein. On the other hand, Platelets are blood cells that cause blood clots and have other functions necessary for regeneration and growth, as they have essential growth factors for the healing and repair of injured tissue. Generally, when PRP is injected directly into the injured tissue of the donor’s tissue, it seeks to use the body’s natural ability to selfregenerate, amplifying the body’s natural growth factors for tissue regeneration.

In orthopaedics, PRP therapies are commonly applicable in treatments like tendinopathies and arthrosis. Scientific studies have already demonstrated the efficiency of the therapy when (i) there is a precise indication of the pathology and (ii) an adjustment of the concentration of blood constituents and injected dose is needed. However, many studies also expose the instability of clinical results due to a lack of standardisation of the procedure using different preparation systems. In this sense, the broad designation of pathologies for PRP treatment is not the only problem.

This project aims the integration, in a single solution, of a procedure for obtaining PRP through a single system with Artificial Inteligence (AI) technology. CoSMO PRP will be capable of (i) modulating the obtaining process from patient-specific conditions, (ii) recording data from a clinical study conducted, (iii) allowing objective analyses before or after treatment, (iv) enabling health professionals to mitigate the variables of the procedure, (v) aiming at better clinical results in osteoarthritis treatment and (vi) contributing to the advancement of the current state of the science of PRP. This project success may enhance the adoption of clinical practices less evasive directly impacting on the treatment of pathologies, and improving the quality of life of patients.